Source: Journal of Investigational Allergology and Clinical Immunology. Unidade: FMRP
Subjects: ANTI-HISTAMÍNICOS, URTICÁRIA, IMUNOTERAPIA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
ENSINA, Luis Felipe et al. H1-antihistamines may no longer be necessary for patients with refractory chronic spontaneous urticaria after initiation of omalizumab. Journal of Investigational Allergology and Clinical Immunology, v. 30, n. 2, p. 145-147, 2020Tradução . . Disponível em: https://doi.org/10.18176/jiaci.0464. Acesso em: 17 ago. 2024.APA
Ensina, L. F., Arruda, L. K. de P., Campos, R. A., Criado, R. F., Rodrigues Valle, S. O., Melo, J. M. L., et al. (2020). H1-antihistamines may no longer be necessary for patients with refractory chronic spontaneous urticaria after initiation of omalizumab. Journal of Investigational Allergology and Clinical Immunology, 30( 2), 145-147. doi:10.18176/jiaci.0464NLM
Ensina LF, Arruda LK de P, Campos RA, Criado RF, Rodrigues Valle SO, Melo JML, Oliveira JCS, Dortas Júnior SD, Cusato-Ensina AP, Camelo-Nunes IC, Agondi RC. H1-antihistamines may no longer be necessary for patients with refractory chronic spontaneous urticaria after initiation of omalizumab [Internet]. Journal of Investigational Allergology and Clinical Immunology. 2020 ; 30( 2): 145-147.[citado 2024 ago. 17 ] Available from: https://doi.org/10.18176/jiaci.0464Vancouver
Ensina LF, Arruda LK de P, Campos RA, Criado RF, Rodrigues Valle SO, Melo JML, Oliveira JCS, Dortas Júnior SD, Cusato-Ensina AP, Camelo-Nunes IC, Agondi RC. H1-antihistamines may no longer be necessary for patients with refractory chronic spontaneous urticaria after initiation of omalizumab [Internet]. Journal of Investigational Allergology and Clinical Immunology. 2020 ; 30( 2): 145-147.[citado 2024 ago. 17 ] Available from: https://doi.org/10.18176/jiaci.0464